{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:56:38Z","timestamp":1793408198155,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1001\/jamacardio.2019.0325","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T11:32:16Z","timestamp":1549971136000},"page":"332","source":"Crossref","is-referenced-by-count":205,"title":["Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices"],"prefix":"10.1001","volume":"4","author":[{"given":"Eric A.","family":"Secemsky","sequence":"first","affiliation":[{"name":"Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Kundi","sequence":"additional","affiliation":[{"name":"Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jaff","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Krawisz","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Beckman","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Mustapha","sequence":"additional","affiliation":[{"name":"Advanced Cardiac & Vascular Amputation Prevention Centers, Grand Rapids, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rosenfield","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"24","key":"hoi190009r1","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials.","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"hoi190009r4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/2229-3485.86872","article-title":"Survival analysis in clinical trials: basics and must know areas.","volume":"2","author":"Singh","year":"2011","journal-title":"Perspect Clin Res"},{"issue":"1","key":"hoi190009r5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.106.614859","article-title":"Survival methods.","volume":"115","author":"Rao","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"hoi190009r6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"hoi190009r7","doi-asserted-by":"publisher","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial.","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"13","key":"hoi190009r8","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"hoi190009r9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial.","volume":"25","author":"Iida","year":"2018","journal-title":"J Endovasc Ther"},{"issue":"2","key":"hoi190009r10","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.jvs.2018.05.058","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.","volume":"68","author":"Mohapatra","year":"2018","journal-title":"J Vasc Surg"},{"issue":"16","key":"hoi190009r12","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jcin.2016.06.008","article-title":"Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials.","volume":"9","author":"Giacoppo","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"hoi190009r13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease.","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"hoi190009r14","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions [published online April 24, 2018].","author":"Feldman","journal-title":"Catheter Cardiovasc Interv"},{"key":"hoi190009r15","doi-asserted-by":"publisher","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting.","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"hoi190009r11","author":"Jones"},{"key":"hoi190009r2","unstructured":"McKeownLA. Two trials halted in wake of study linking paclitaxel-coated devices to deaths in PAD. https:\/\/www.tctmd.com\/news\/two-trials-halted-wake-study-linking-paclitaxel-coated-devices-deaths-pad. Accessed December 19, 2018."},{"key":"hoi190009r3","unstructured":"US Food & Drug Administration. Treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality\u2014letter to health care providers. https:\/\/www.fda.gov\/MedicalDevices\/Safety\/LetterstoHealthCareProviders\/ucm629589.htm. Accessed January 21, 2019."}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamacardiology\/article-pdf\/4\/4\/332\/17483848\/jamacardiology_secemsky_2019_oi_190009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T16:03:36Z","timestamp":1555517016000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2019.0325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.0325","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735384670.793558196","asserted-by":"object"}]},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}